[HTML][HTML] Osteoarthritis year 2012 in review: clinical

MC Hochberg - Osteoarthritis and Cartilage, 2012 - Elsevier
Epidemiologic and clinical research in osteoarthritis (OA) continues to focus on analytic and
descriptive epidemiology, and the role of both nonpharmacologic and pharmacologic …

[HTML][HTML] Osteoarthritis year in review 2022: biology

S Han - Osteoarthritis and cartilage, 2022 - Elsevier
The field of osteoarthritis (OA) biology is rapidly evolving and brilliant progress has been
made this year as well. Landmark studies of OA biology published in 2021 and early 2022 …

Mass spectrometry-based biomarkers for knee osteoarthritis: a systematic review

MJJ Haartmans, KS Emanuel, GJM Tuijthof… - Expert review of …, 2021 - Taylor & Francis
Introduction Knee osteoarthritis (OA) is a joint disease, affecting multiple tissues in the joint.
Early detection and intervention may delay OA development and avoid total knee …

[HTML][HTML] Osteoarthritis year 2012 in review: biology

PM Van der Kraan - Osteoarthritis and Cartilage, 2012 - Elsevier
This review focuses on recent findings in pathobiology of osteoarthritis (OA). The progress in
this field will be illustrated based on three questions; 1. What factors maintain or alter the …

[HTML][HTML] Osteoarthritis year in review 2023: Biology

AJ Roelofs, C De Bari - Osteoarthritis and cartilage, 2023 - Elsevier
Great progress continues to be made in our understanding of the multiple facets of
osteoarthritis (OA) biology. Here, we review the major advances in this field and progress …

Early biomarkers of joint damage in rheumatoid and psoriatic arthritis

A Mc Ardle, B Flatley, SR Pennington… - Arthritis research & …, 2015 - Springer
Joint destruction, as evidenced by radiographic findings, is a significant problem for patients
suffering from rheumatoid arthritis and psoriatic arthritis. Inherently irreversible and …

Investigational drugs for the treatment of osteoarthritis, an update on recent developments

Z Zhu, J Li, G Ruan, G Wang, C Huang… - Expert opinion on …, 2018 - Taylor & Francis
Introduction: Osteoarthritis (OA) is the leading cause of pain, loss of function, and disability
among elderly, with the knee the most affected joint. It is a heterogeneous condition …

Osteoarthritis endotype discovery via clustering of biochemical marker data

F Angelini, P Widera, A Mobasheri, J Blair… - Annals of the …, 2022 - ard.bmj.com
Objectives Osteoarthritis (OA) patient stratification is an important challenge to design
tailored treatments and drive drug development. Biochemical markers reflecting joint tissue …

Osteoarthritis research priorities: a report from a EULAR ad hoc expert committee

PG Conaghan, M Kloppenburg, G Schett… - Annals of the …, 2014 - ard.bmj.com
Osteoarthritis (OA) currently affects over 40 million Europeans, with its associated personal
suffering and significant economic burden for health systems set to dramatically escalate in …

[HTML][HTML] Recent advances in the treatment of osteoarthritis

S Grässel, D Muschter - F1000Research, 2020 - ncbi.nlm.nih.gov
Osteoarthritis (OA) is one of the most debilitating diseases and is associated with a high
personal and socioeconomic burden. So far, there is no therapy available that effectively …